Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Beauchamp, Kyle A.
318  Ergebnisse:
Personensuche X
?
1

Assessing the utility of molecular diagnostic classificatio..:

Moore, Elle C. ; Blobe, Gerard C. ; DeVito, Nicholas C....
Cancer Medicine.  12 (2023)  19 - p. 19394-19405 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Validation of a Transcriptome-Based Assay for Classifying C..:

Michuda, Jackson ; Breschi, Alessandra ; Kapilivsky, Joshuah...
Molecular Diagnosis & Therapy.  27 (2023)  4 - p. 499-511 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Clinical impact and cost-effectiveness of a 176-condition e..:

Beauchamp, Kyle A. ; Johansen Taber, Katherine A. ; Muzzey, Dale
Genetics in Medicine.  24 (2022)  4 - p. 968 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Clinical validity of expanded carrier screening: Evaluating..:

Balzotti, Marie ; Meng, Linyan ; Muzzey, Dale...
Human Mutation.  41 (2020)  8 - p. 1365-1371 , 2020
Link: https://doi.org/10.1002/..
 
?
5

Clinical utility of expanded carrier screening: results-gui..:

Johansen Taber, Katherine A. ; Beauchamp, Kyle A. ; Lazarin, Gabriel A....
Genetics in Medicine.  21 (2019)  5 - p. 1041-1048 , 2019
Link: https://doi.org/10.1038/..
 
?
6

886: Detection of copy-number variants in expanded carrier ..:

Muzzey, Dale ; Grauman, Peter V. ; Spurka, Lindsay.
American Journal of Obstetrics and Gynecology.  220 (2019)  1 - p. S575 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Clinical impact and cost-effectiveness of a 176-condition e..:

Beauchamp, Kyle A. ; Johansen Taber, Katherine A. ; Muzzey, Dale
Genetics in Medicine.  21 (2019)  9 - p. 1948-1957 , 2019
Link: https://doi.org/10.1038/..
 
?
8

893: Clinical utility of expanded carrier screening: Result..:

Taber, Katie Johansen ; Beauchamp, Kyle ; Lazarin, Gabriel...
American Journal of Obstetrics and Gynecology.  220 (2019)  1 - p. S578-S579 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Sequencing-Based Carrier Screening for Cystic Fibrosis: Rea..:

Beauchamp, Kyle ; Grauman, Peter ; Spurka, Lindsay..
Obstetrics & Gynecology.  133 (2019)  1 - p. 166-166 , 2019
Link: https://doi.org/10.1097/..
 
?
10

The dynamic conformational landscape of the protein methylt..:

Chen, Shi ; Wiewiora, Rafal P ; Meng, Fanwang...
eLife.  8 (2019)  - p. , 2019
Link: https://doi.org/10.7554/..
 
?
11

Sequencing as a first-line methodology for cystic fibrosis ..:

Beauchamp, Kyle A. ; Johansen Taber, Katherine A. ; Grauman, Peter V....
Genetics in Medicine.  21 (2019)  11 - p. 2569-2576 , 2019
Link: https://doi.org/10.1038/..
 
?
12

Correction: Sequencing as a first-line methodology for cyst..:

Beauchamp, Kyle A. ; Taber, Katherine A. Johansen ; Grauman, Peter V....
Genetics in Medicine.  21 (2019)  10 - p. 2407-2408 , 2019
Link: https://doi.org/10.1038/..
 
?
13

Clinical Utility of Expanded Carrier Screening: Actionabili..:

Taber, Katie Johansen ; Beauchamp, Kyle ; Lazarin, Gabriel..
Obstetrics & Gynecology.  133 (2019)  1 - p. 117S-117S , 2019
Link: https://doi.org/10.1097/..
 
?
14

Quantifying Configuration-Sampling Error in Langevin Simula..:

Fass, Josh ; Sivak, David A. ; Crooks, Gavin E....
Entropy.  20 (2018)  5 - p. 318 , 2018
Link: https://doi.org/10.3390/..
 
?
15

Validation of an Expanded Carrier Screen that Optimizes Sen..:

Muzzey, Dale ; Kang, Hyunseok P ; Mar-Heyming, Rebecca...
Clinical Chemistry.  64 (2018)  7 - p. 1063-1073 , 2018
Link: https://doi.org/10.1373/..
 
1-15